Klotho Neurosciences, Inc.
KLTO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $9,335 | $1,076,207 | $1,076,207 | $1,076,207 |
| - Cash | $64 | $3 | $76 | $301 |
| + Debt | $272 | $1,467 | $1,348 | $0 |
| Enterprise Value | $9,543 | $1,077,672 | $1,077,479 | $1,075,906 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$5,794 | -$631 | -$574 | -$1,109 |
| % Margin | – | – | – | – |
| Net Income | -$6,150 | -$707 | -$599 | -$1,109 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.32 | -0.001 | -0.001 | -0.001 |
| % Growth | -45,614.3% | -16.7% | 45.5% | – |
| Operating Cash Flow | -$2,947 | -$447 | -$600 | -$284 |
| Capital Expenditures | -$123 | -$14 | -$125 | $0 |
| Free Cash Flow | -$3,070 | -$461 | -$725 | -$284 |